• ICR report shows lag in UK patient access to new cancer drugs pharmaceutical-technology
    December 05, 2018
    A new report by The Institute of Cancer Research, London (ICR) has revealed an increase of nearly one year in delay between clinical trials, regulatory approvals and patient access to new cancer medications....
PharmaSources Customer Service